| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f284ae515fa8c17efd48d90eed89bd1e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52 |
| filingDate |
2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f91a703220aca657c7dcbcc2be1273a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb2b91a83c365dd885303c08c1c74c1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54f88484ac8cb1b13fae1703cfceac73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce818fa631861927e8a51bf5b23c3483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf1908c3d2416cbb1cf89a3503efb764 |
| publicationDate |
2010-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20100085041-A |
| titleOfInvention |
SDF-1 glycosaminoglycan antagonist and use thereof |
| abstract |
The present invention relates to novel mutations of human stromal cell derived factor-1 that exhibit increased glycosaminoglycan (GAG) binding affinity and suppressed or down-regulated wild type GPCR activity compared to wild type SDF-1, and these mutations. It relates to a method of preparing the same and to the use thereof for the manufacture of a medicament for the treatment of cancer. |
| priorityDate |
2007-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |